| A1 Recovery & Treatment Llc | |
|
100 E Euclid Ave Suite 157 Des Moines IA 50313-4511 | |
| (515) 381-3001 | |
| Not Available |
| Full Name | A1 Recovery & Treatment Llc |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 100 E Euclid Ave, Des Moines, Iowa |
| Authorized Official Name and Position | Kevin Bradford (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 5153813001 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| A1 Recovery & Treatment Llc 100 E Euclid Ave Suite 157 Des Moines IA 50313-4511 Ph: (515) 381-3001 | A1 Recovery & Treatment Llc 100 E Euclid Ave Suite 157 Des Moines IA 50313-4511 Ph: (515) 381-3001 |
| NPI Number | 1740712678 |
|---|---|
| Provider Enumeration Date | 03/30/2017 |
| Last Update Date | 03/30/2017 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740712678 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | 1397 (Iowa) | Primary |
News Archive
An extensive genomic study of the childhood cancer neuroblastoma reinforces the challenges in treating the most aggressive forms of this disease. Contrary to expectations, the scientists found relatively few recurrent gene mutations—mutations that would suggest new targets for neuroblastoma treatment. Instead, say the researchers, they have now refocused on how neuroblastoma tumors evolve in response to medicine and other factors.
Expression Analysis today announced that it and Illumina, Inc. are jointly funding a Cancer GWAS (Genome-Wide Association Study) and Data Analysis Grant program to support cutting-edge projects that show promise in identifying genetic elements important to cancer research and treatment.
Bristol-Myers Squibb Company today announced interim results from a Phase IIb clinical trial (COMMAND-1) of 395 treatment-naïve, genotype 1 and 4 hepatitis C infected patients in which two doses of the investigational NS5A replication complex inhibitor daclatasvir (BMS-790052), in combination with peginterferon alfa and ribavirin (alfa/RBV), achieved higher virologic response rates through Week 12 than the alfa/RBV control group, with comparable rates of adverse events.
Under the Affordable Care Act (ACA), changes in income and family circumstances are likely to produce frequent transitions in eligibility for Medicaid and health insurance Marketplace coverage for low- and middle-income adults.
› Verified 8 days ago
Mercy Ruan Neurology Clinic Central Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1111 6th Ave, East Tower Suite A100, Des Moines, IA 50314 Phone: 515-358-0011 Fax: 515-358-0099 | |
Multicultural Institute Of Therapeutic Excellence Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4313 University Ave, Des Moines, IA 50311 Phone: 515-802-2487 | |
Beyond Wellness Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 699 Walnut St Ste 400, Des Moines, IA 50309 Phone: 855-380-6136 | |
Unitypoint Health - Des Moines Iowa Methodist Medical Center Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 700 E University Ave, Des Moines, IA 50316 Phone: 515-263-5612 | |
The Healing Space Counseling Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3810 1/2 Douglas Ave, Des Moines, IA 50310 Phone: 515-423-2333 | |
Openloop Healthcare Partners Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 317 6th Ave Ste 400, Des Moines, IA 50309 Phone: 515-216-0962 | |
Child Guidance Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 808 5th Ave, Des Moines, IA 50309 Phone: 515-244-2267 |